The impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome

Researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial infarction (MI) risk or other long-term outcomes such as death at five years in individuals with suspected acute coronary syndrome.

Lack of Institutional Support a Top Reason Why Doctors Hesitate to Treat Addiction

A lack of institutional support topped the list of reasons why clinicians may be reluctant to intervene in addiction, according to a systematic review of

July 18, 2024

Novo Nordisk continues diabetes, obesity sales rise, but still on the back foot with Wegovy supply

As demand for Novo Nordisk’s GLP-1 products continues unabated, all eyes are on the pharma giant to meet demand. Starting this month, Novo has more

February 1, 2024

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.